Stability of GLP-1 analogs To evaluate the stability of GLP-1 and its analogs against DPP-IV activity, peptides were incubated at an initial concentration of 100 nM in DMEM containing 10% FBS or in 100% FBS at 37 for 0, 12, 24, 48, 72, and 96 hours in the presence or absence of 0.2 mM DPP-IV inhibitor diprotin A (Sigma-Aldrich, St Louis, MO, USA)
Journal of Dermatological Treatment, 23(2), 97102
Gradually add the measured amount of powdered glutathione to the sterile vial containing the saline solution
Dry eye disease: a review of epidemiology in taiwan, and its clinical treatment and merits
The researchers noted a 16% decrease in the odds of someone being diagnosed with epilepsy if they take Trulicity or another GLP-1